Frontiers in Pharmacology · 2018 · 48 citations · 24 references
MedicineCell BiologyMolecular BiologyBone MetabolismCell SignalingSignal TransductionBone Density RegulationBone FormationBone ResorptionOsteoclast BiologyOsteoclast FunctionOsteoporosisCitrus FruitsInterferon Regulatory Factor ActivationJnk Pathway ActivationMapk SignalingNf-κb SignalingNuclear Factor Kappa B SignalingOsteoclast PrecursorsRankl-mediated Osteoclastogenesis
Bone homeostasis and resorption is regulated by the proper activation of osteoclasts, whose stimulation largely depends on the receptor activator of nuclear factor κB ligand (RANKL)-RANK signaling. Herein, for the first time, we showed that interferon regulatory factor (Irf)-3 was intimately involved in RANKL-induced osteoclast formation. In addition, hesperetin (Hes) derived from citrus fruit could inhibit RANKL-induced osteoclast differentiation and maturation among three types of osteoclast precursors with inhibited formation of F-actin rings and resorption pits on bone slices. More importantly, by using SP600125, a selective Jnk inhibitor, we showed that Hes was able to significantly attenuate the Jnk downstream expression of Irf-3 and c-Jun, thereby inactivating NF-κB/MAPK signaling and transcriptional factor NFATc-1, leading to suppression of osteoclast-specific genes, which resulted in impaired osteoclastogenesis and functionality. An ovariectomized (OVX) osteoporosis mouse model demonstrated that Hes could increase trabecular bone volume fractions (BV/TV), trabecular thickness, and trabecular number, whereas it decreased trabecular separation in OVX mice with well-preserved trabecular bone architecture and decreased levels of TRAP-positive osteoclasts. This is further evidenced by the diminished serum expression of bone resorption marker CTX and enhanced production of osteoblastic ALP in vivo . Taken together, these results suggested that Hes could inhibit Jnk-mediated Irf-3/c-Jun activation, thus attenuating RANKL-induced osteoclast formation and function both in vitro and in vivo .
24
PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis
Hui Xie, Zhuang Cui, Long Wang et al. · Nature Medicine · 2014 · 944 citations · Full text
Mónica Comalada, Isabel Ballester, Elvira Bailón et al. · Biochemical Pharmacology · 2006 · 430 citations
TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers
Anurag Singh, Michael F. Sweeney, Min Yu et al. · Cell · 2012 · 267 citations · Full text
Medicine, Cancer Biology, Oncology +14